MedPath

Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia

Not Applicable
Completed
Conditions
General Glucocorticoid Resistance
Interventions
Genetic: blood collection for mutation characterization
Registration Number
NCT02810496
Lead Sponsor
CHU de Reims
Brief Summary

As the investigators observed a case of glucocorticoid mutation revealed by incidentally discovered bilateral adrenal nodular hyperplasia, it was postulated that this molecular anormality could be more frequent than previously described. To validate this hypothesis, it was decided to study 150 multicenter consecutive patients, presenting with incidentally discovered bilateral adrenal masses without clinical signs of Cushing's disease. In all these patients GR gene will be studied, mutations will be detected and described, functional disturbance will be tested. Usual polymorphisms will be described. Correlation between clinical signs, hormonal and morphological abnormalities and presence or absence of GR mutations will be searched.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • patients more than 18 years of age
  • patients with bilateral adrenal masses
Exclusion Criteria
  • Refusing to participate in the study
  • Protected by law
  • Have obvious signs of Cushing's syndrome
  • No progressive neoplastic disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
patientblood collection for mutation characterization-
Primary Outcome Measures
NameTimeMethod
frequency of mutationsDAY 0
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Reims

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath